APPL2 Antibodies

Santa Cruz Biotechnology delivers a wide array of APPL2 monoclonal antibodies for research focused on understanding APPL2 protein functions. APPL2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). APPL2, or adaptor protein containing PH domain, PTB domain, and leucine zipper, plays a crucial role in cellular signaling and endocytosis. APPL2 actively participates in the regulation of insulin signaling pathways. Research has shown that APPL2 significantly influences cell growth and differentiation processes. Current studies indicate that APPL2 may have important implications in metabolic disorders and cancer development. Understanding APPL2 functions continues to reveal new insights into cellular mechanisms. Investigating APPL2 opens new possibilities for therapeutic interventions in various diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of APPL2's role in human health and disease.